Tr1X

Tr1X

tr1x.biogreenhouse
45
Reputation
Mid
1 open positions
Last updated Aug 2, 2026
30 employees

Senior Director, Quality

$225k–$260k/year
71
High

About Tr1X Tr1X is a clinical-stage biotechnology company developing engineered Tr1 cell therapies to restore immune balance in autoimmune and inflammatory diseases. Leveraging the unique biology of Tr1 cells, the company is advancing a pipeline of off-the-shelf allogeneic and in vivo

OtherDirectorSenior
See 2 similar>
1 0 0 5d ago

Insights will appear once this company has published more listings.